annual EBITDA:
$928.62M-$46.64M(-4.78%)Summary
- As of today (September 15, 2025), CRL annual EBITDA is $928.62 million, with the most recent change of -$46.64 million (-4.78%) on December 28, 2024.
- During the last 3 years, CRL annual EBITDA has risen by +$60.65 million (+6.99%).
- CRL annual EBITDA is now -4.78% below its all-time high of $975.26 million, reached on December 30, 2023.
Performance
CRL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$220.89M+$36.67M(+19.90%)Summary
- As of today (September 15, 2025), CRL quarterly EBITDA is $220.89 million, with the most recent change of +$36.67 million (+19.90%) on June 28, 2025.
- Over the past year, CRL quarterly EBITDA has dropped by -$17.61 million (-7.38%).
- CRL quarterly EBITDA is now -38.17% below its all-time high of $357.25 million, reached on December 31, 2022.
Performance
CRL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$528.39M-$17.61M(-3.23%)Summary
- As of today (September 15, 2025), CRL TTM EBITDA is $528.39 million, with the most recent change of -$17.61 million (-3.23%) on June 28, 2025.
- Over the past year, CRL TTM EBITDA has dropped by -$477.73 million (-47.48%).
- CRL TTM EBITDA is now -50.46% below its all-time high of $1.07 billion, reached on September 30, 2023.
Performance
CRL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.8% | -7.4% | -47.5% |
| 3 y3 years | +7.0% | -1.5% | -39.3% |
| 5 y5 years | +57.2% | +37.6% | -12.1% |
CRL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.8% | +7.0% | -38.2% | +355.5% | -50.5% | at low |
| 5 y | 5-year | -4.8% | +57.2% | -38.2% | +355.5% | -50.5% | at low |
| alltime | all time | -4.8% | +2365.1% | -38.2% | +135.1% | -50.5% | +225.5% |
CRL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $220.89M(+19.9%) | $528.39M(-3.2%) |
| Mar 2025 | - | $184.23M(-313.1%) | $546.00M(-6.0%) |
| Dec 2024 | $928.62M(-4.8%) | -$86.45M(-141.2%) | $581.14M(-41.3%) |
| Sep 2024 | - | $209.72M(-12.1%) | $990.36M(-1.6%) |
| Jun 2024 | - | $238.50M(+8.7%) | $1.01B(-0.3%) |
| Mar 2024 | - | $219.37M(-32.0%) | $1.01B(-2.2%) |
| Dec 2023 | $975.26M(+2.0%) | $322.76M(+43.1%) | $1.03B(-3.2%) |
| Sep 2023 | - | $225.49M(-6.6%) | $1.07B(+1.6%) |
| Jun 2023 | - | $241.38M(-0.5%) | $1.05B(+1.7%) |
| Mar 2023 | - | $242.49M(-32.1%) | $1.03B(+4.8%) |
| Dec 2022 | $956.46M(+10.2%) | $357.25M(+70.9%) | $986.15M(+13.2%) |
| Sep 2022 | - | $209.09M(-6.8%) | $871.33M(+0.1%) |
| Jun 2022 | - | $224.24M(+14.7%) | $870.66M(+1.5%) |
| Mar 2022 | - | $195.58M(-19.3%) | $858.21M(+4.6%) |
| Dec 2021 | $867.97M(+25.1%) | $242.43M(+16.3%) | $820.16M(-2.8%) |
| Sep 2021 | - | $208.41M(-1.6%) | $844.18M(-0.6%) |
| Jun 2021 | - | $211.79M(+34.4%) | $849.49M(+6.4%) |
| Mar 2021 | - | $157.53M(-40.9%) | $798.21M(+3.9%) |
| Dec 2020 | $693.88M(+17.5%) | $266.45M(+24.7%) | $768.47M(+12.4%) |
| Sep 2020 | - | $213.72M(+33.2%) | $683.78M(+13.8%) |
| Jun 2020 | - | $160.51M(+25.6%) | $600.75M(+5.5%) |
| Mar 2020 | - | $127.79M(-29.7%) | $569.21M(+1.1%) |
| Dec 2019 | $590.68M(+13.6%) | $181.76M(+39.1%) | $563.06M(+9.4%) |
| Sep 2019 | - | $130.69M(+1.3%) | $514.67M(-0.7%) |
| Jun 2019 | - | $128.97M(+6.0%) | $518.07M(-0.6%) |
| Mar 2019 | - | $121.64M(-8.8%) | $521.43M(+2.8%) |
| Dec 2018 | $519.91M(+21.4%) | $133.37M(-0.5%) | $507.23M(+4.8%) |
| Sep 2018 | - | $134.09M(+1.3%) | $484.12M(+4.3%) |
| Jun 2018 | - | $132.33M(+23.2%) | $464.10M(+3.6%) |
| Mar 2018 | - | $107.44M(-2.6%) | $447.89M(-2.2%) |
| Dec 2017 | $428.32M(+9.1%) | $110.26M(-3.3%) | $457.89M(+0.8%) |
| Sep 2017 | - | $114.07M(-1.8%) | $454.41M(+4.5%) |
| Jun 2017 | - | $116.12M(-1.1%) | $434.78M(+4.9%) |
| Mar 2017 | - | $117.44M(+10.0%) | $414.31M(+9.8%) |
| Dec 2016 | $392.75M(+25.5%) | $106.78M(+13.1%) | $377.29M(+7.8%) |
| Sep 2016 | - | $94.44M(-1.3%) | $349.88M(+4.1%) |
| Jun 2016 | - | $95.65M(+18.9%) | $336.25M(+2.4%) |
| Mar 2016 | - | $80.42M(+1.3%) | $328.45M(+7.6%) |
| Dec 2015 | $312.97M(+6.1%) | $79.36M(-1.8%) | $305.38M(+3.5%) |
| Sep 2015 | - | $80.82M(-8.0%) | $294.99M(+2.7%) |
| Jun 2015 | - | $87.85M(+53.2%) | $287.13M(+3.5%) |
| Mar 2015 | - | $57.34M(-16.9%) | $277.50M(-3.0%) |
| Dec 2014 | $294.94M(+15.5%) | $68.97M(-5.5%) | $285.99M(+5.0%) |
| Sep 2014 | - | $72.96M(-6.7%) | $272.25M(+0.4%) |
| Jun 2014 | - | $78.22M(+18.8%) | $271.25M(+5.2%) |
| Mar 2014 | - | $65.84M(+19.2%) | $257.83M(+0.7%) |
| Dec 2013 | $255.46M(+0.9%) | $55.23M(-23.2%) | $255.93M(+0.0%) |
| Sep 2013 | - | $71.96M(+11.0%) | $255.87M(+6.0%) |
| Jun 2013 | - | $64.80M(+1.3%) | $241.38M(-1.4%) |
| Mar 2013 | - | $63.94M(+15.9%) | $244.72M(+0.1%) |
| Dec 2012 | $253.16M | $55.17M(-4.0%) | $244.36M(-3.3%) |
| Sep 2012 | - | $57.46M(-15.7%) | $252.79M(-0.1%) |
| Jun 2012 | - | $68.14M(+7.2%) | $252.98M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $63.58M(-0.0%) | $260.12M(-0.1%) |
| Dec 2011 | $284.14M(+19.7%) | $63.60M(+10.3%) | $260.48M(-282.3%) |
| Sep 2011 | - | $57.65M(-23.4%) | -$142.92M(-16.9%) |
| Jun 2011 | - | $75.28M(+17.7%) | -$172.03M(-11.7%) |
| Mar 2011 | - | $63.94M(-118.8%) | -$194.87M(-5.0%) |
| Dec 2010 | $237.31M(-13.8%) | -$339.80M(-1290.3%) | -$205.15M(-208.4%) |
| Sep 2010 | - | $28.55M(-45.6%) | $189.23M(-18.3%) |
| Jun 2010 | - | $52.43M(-2.3%) | $231.53M(-9.1%) |
| Mar 2010 | - | $53.66M(-1.7%) | $254.63M(-3.3%) |
| Dec 2009 | $275.33M(-19.4%) | $54.59M(-23.0%) | $263.20M(-162.5%) |
| Sep 2009 | - | $70.85M(-6.2%) | -$421.17M(+5.3%) |
| Jun 2009 | - | $75.54M(+21.4%) | -$399.97M(+4.9%) |
| Mar 2009 | - | $62.23M(-109.9%) | -$381.37M(+7.2%) |
| Dec 2008 | $341.42M(+8.9%) | -$629.78M(-784.2%) | -$355.82M(-200.0%) |
| Sep 2008 | - | $92.05M(-2.2%) | $355.65M(+1.7%) |
| Jun 2008 | - | $94.13M(+7.2%) | $349.82M(+4.6%) |
| Mar 2008 | - | $87.78M(+7.5%) | $334.27M(+3.9%) |
| Dec 2007 | $313.57M(+13.2%) | $81.68M(-5.3%) | $321.81M(+4.5%) |
| Sep 2007 | - | $86.22M(+9.7%) | $307.81M(+4.3%) |
| Jun 2007 | - | $78.59M(+4.4%) | $295.00M(+3.4%) |
| Mar 2007 | - | $75.31M(+11.3%) | $285.19M(+96.8%) |
| Dec 2006 | $276.96M(+1.6%) | $67.69M(-7.8%) | $144.94M(+11.8%) |
| Sep 2006 | - | $73.40M(+6.7%) | $129.63M(-6.3%) |
| Jun 2006 | - | $68.79M(-205.9%) | $138.34M(+0.5%) |
| Mar 2006 | - | -$64.93M(-224.0%) | $137.62M(-49.8%) |
| Dec 2005 | $272.63M(+31.9%) | $52.38M(-36.2%) | $274.02M(+0.9%) |
| Sep 2005 | - | $82.11M(+20.6%) | $271.66M(+12.5%) |
| Jun 2005 | - | $68.06M(-4.8%) | $241.40M(+7.0%) |
| Mar 2005 | - | $71.47M(+42.9%) | $225.69M(+11.8%) |
| Dec 2004 | $206.63M(+21.7%) | $50.02M(-3.5%) | $201.92M(+2.9%) |
| Sep 2004 | - | $51.86M(-0.9%) | $196.18M(+5.3%) |
| Jun 2004 | - | $52.34M(+9.7%) | $186.23M(+5.6%) |
| Mar 2004 | - | $47.70M(+7.7%) | $176.34M(+3.9%) |
| Dec 2003 | $169.82M(+16.1%) | $44.28M(+5.7%) | $169.67M(+3.9%) |
| Sep 2003 | - | $41.91M(-1.3%) | $163.25M(+1.6%) |
| Jun 2003 | - | $42.46M(+3.5%) | $160.70M(+3.8%) |
| Mar 2003 | - | $41.03M(+8.4%) | $154.80M(+4.6%) |
| Dec 2002 | $146.25M(+20.8%) | $37.86M(-3.8%) | $147.99M(+5.1%) |
| Sep 2002 | - | $39.36M(+7.7%) | $140.80M(+5.9%) |
| Jun 2002 | - | $36.56M(+6.8%) | $132.94M(+4.0%) |
| Mar 2002 | - | $34.22M(+11.6%) | $127.81M(+7.5%) |
| Dec 2001 | $121.03M(+47.9%) | $30.67M(-2.6%) | $118.86M(+11.3%) |
| Sep 2001 | - | $31.49M(+0.2%) | $106.78M(+9.2%) |
| Jun 2001 | - | $31.44M(+24.4%) | $97.81M(+13.3%) |
| Mar 2001 | - | $25.27M(+36.0%) | $86.36M(+2.9%) |
| Dec 2000 | $81.83M(+53.3%) | $18.58M(-17.5%) | $83.93M(+28.4%) |
| Sep 2000 | - | $22.53M(+12.7%) | $65.35M(+52.6%) |
| Jun 2000 | - | $19.98M(-12.5%) | $42.82M(+87.5%) |
| Mar 2000 | - | $22.84M | $22.84M |
| Dec 1999 | $53.36M(+15.5%) | - | - |
| Dec 1998 | $46.22M(+22.7%) | - | - |
| Dec 1997 | $37.67M(-1.9%) | - | - |
| Dec 1996 | $38.42M | - | - |
FAQ
- What is Charles River Laboratories International, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual EBITDA year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly EBITDA year-on-year change?
- What is Charles River Laboratories International, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. TTM EBITDA year-on-year change?
What is Charles River Laboratories International, Inc. annual EBITDA?
The current annual EBITDA of CRL is $928.62M
What is the all time high annual EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual EBITDA is $975.26M
What is Charles River Laboratories International, Inc. annual EBITDA year-on-year change?
Over the past year, CRL annual EBITDA has changed by -$46.64M (-4.78%)
What is Charles River Laboratories International, Inc. quarterly EBITDA?
The current quarterly EBITDA of CRL is $220.89M
What is the all time high quarterly EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly EBITDA is $357.25M
What is Charles River Laboratories International, Inc. quarterly EBITDA year-on-year change?
Over the past year, CRL quarterly EBITDA has changed by -$17.61M (-7.38%)
What is Charles River Laboratories International, Inc. TTM EBITDA?
The current TTM EBITDA of CRL is $528.39M
What is the all time high TTM EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high TTM EBITDA is $1.07B
What is Charles River Laboratories International, Inc. TTM EBITDA year-on-year change?
Over the past year, CRL TTM EBITDA has changed by -$477.73M (-47.48%)